Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis

1 February 2004

journal article
research article
Published by Springer Nature in Medical Microbiology and Immunology

Vol. 193 (1) , 19-25
https://doi.org/10.1007/s00430-002-0170-x

Abstract

The components of antigen 85 complex of Mycobacterium tuberculosis (Ag 85A, Ag 85B and Ag 85C), due to their immunodominant and secretory nature, represent promising protective antigen candidates and have been used in numerous vaccine preparations. We have used recombinant Bacille Calmette Guerin (BCG) strains overexpressing Ag 85A and Ag 85C to immunize BALB/c mice to investigate the immunogenicity of these strains. Mice immunized with recombinant BCG strains exhibited an increased humoral immune response when compared to mice immunized with wild-type BCG. The recombinant BCG strain overexpressing Ag 85A also induced an increased Th1-like response, characterized by elevated levels of IFN-γ in antigen stimulated splenocyte cultures and a strong IgG2a antibody response, when compared to wild-type BCG. Immunization with recombinant BCG strain overexpressing Ag 85C, on the other hand did not elicit increased IFN-γ secretion on restimulation of splenocytes in vitro.

Keywords

This publication has 19 references indexed in Scilit:

Recombinant BCG vaccines
Vaccine, 2001
Recombinant bacillus Calmette–Guérin (BCG) vaccines expressing theMycobacterium tuberculosis30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
Proceedings of the National Academy of Sciences, 2000
Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens ofM. tuberculosis
FEMS Microbiology Letters, 2000
Tuberculosis DNA Vaccine Encoding Ag85A Is Immunogenic and Protective When Administered by Intramuscular Needle Injection but Not by Epidermal Gene Gun Bombardment
Infection and Immunity, 2000
Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A
Tubercle and Lung Disease, 1999
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex
Vaccine, 1997
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
Nature Medicine, 1996
Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.
Proceedings of the National Academy of Sciences, 1995
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
The Journal of Experimental Medicine, 1993
TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
Annual Review of Immunology, 1989